School of Medicine
Showing 21-30 of 175 Results
-
Ravi Majeti MD, PhD
Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Virginia and D. K. Ludwig Professor and Professor of Medicine (Hematology/Stem Cell Institute)
Current Research and Scholarly InterestsThe Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.
-
Joshua Makower
Yock Family Professor and Professor of Bioengineering
Current Research and Scholarly InterestsDr. Josh Makower is The Yock Family Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Byers Family Director of the Stanford Mussallem Center for Biodesign, the program he co-founded with Dr. Paul Yock twenty five years ago. Josh helped create the fundamental structure of the Center’s core curriculum and is the chief architect of what is now called “The Biodesign Process.” Over the past 25 years since Josh and Paul founded Biodesign, this curriculum and the associated textbook has been used at Stanford and across the world to train over 20,000 students, faculty and industry leaders on the Biodesign process towards the advancement of medical innovation for the improvement of patient care. These trainees from Stanford and programs across the world have created over 350 companies, impacting almost 100 million patients worldwide. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 12 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed ventures include Moximed, Revelle Aesthetics, X9 and Willow. Josh is also a Senior Advisors to Patient Square Capital/Elevage Medical, and an Advisory Venture Partner with Sofinnova Partners. Josh serves on the boards of Elevage, VentureWell, Setpoint Medical, Imperative Care, ExploraMed, Moximed, Willow, X9 and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering, a Fellow of The National Academy of Inventors and The American Institute for Medical and Biological Engineering, and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.
-
Jose R. Maldonado, MD, FACLP, FACFE
John and Terry Levin Family Professor of Medicine and Professor, by courtesy, of Emergency Medicine and of Medicine
Current Research and Scholarly InterestsPathophysiology and Management of Delirium, Acute Brain Failure and Cognitive Impairment, Neuropsychiatric Sequelae of Traumatic Brain Injury, Factitious Disorder & Munchausen's Syndrome, Cultural Diversity in Medical Care, Psychiatric Complications of Bone Marrow Transplantation, Conversion Disorder, Depression in the Medically Ill, Neuropsychiatric Sequelae of Chronic Fatigue Syndrome.